BioSpace News Archive

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that the company plans to release its first quarter 2023 financial results after the close of the U.S. financial markets on May 9, 2023.

Bright Minds Biosciences Inc. today announced that Alex Vasilkevich, Bright Minds’ Scientific Officer, will present at the 20th International Meeting of the International Society for Serotonin Research (ISSR).

Two scientific abstracts spanning clinical and health economic outcomes research will be presented at the 2023 NKF SCM, showcasing the breadth of Mallinckrodt’s commitment to HRS patients with rapid reduction in kidney function.

TScan Therapeutics, Inc. today announced the appointment of Barbara Klencke, M.D., to its Board of Directors, effective April 6, 2023.

Tiziana Life Sciences Ltd. today announced that poster presentations on intranasal foralumab are being presented at the “Preserving the Brain” scientific conference and exhibit held at the Fondazione Prada in Rong Zhai in Shanghai.

Sernova Corp. today announced that President and Chief Executive Officer, Dr. Philip Toleikis, will present at the upcoming annual Cell & Gene Meeting on the Med to be held April 12-14, 2023 at the Hotel Arts Barcelona in Barcelona, Spain and livestreamed globally.

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the acceptance of three abstracts at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) taking place from May 16-20, 2023 in Los Angeles, CA.

Enveric Biosciences today announced that Joseph Tucker, Ph.D., Chief Executive Officer, will participate in the Benzinga Psychedelics Capital Conference being held Thursday, April 13, 2023, at the Fontainebleau Miami Beach, Florida.

Denali Therapeutics Inc. today announced that new data from the 28-day treatment period of the Phase 1b study of DNL343 in participants with amyotrophic lateral sclerosis (ALS) will be presented at the 75th Annual Meeting of the American Academy of Neurology (AAN), which will be held April 22-27, 2023, in Boston, Massachusetts.

CG Oncology, Inc. today announced acceptance of an oral presentation at the American Urological Association (AUA) 2023 Annual Meeting in Chicago, IL from April 28-May 1, 2023.